XML 15 R4.htm IDEA: XBRL DOCUMENT v3.20.4
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended 9 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2020
Dec. 31, 2019
Revenues [1] $ 34,172 $ 31,655 $ 95,973 $ 83,479
Cost of revenues 13,519 16,852 33,695 36,886
Gross profit 20,653 14,803 62,278 46,593
Operating expenses:        
Selling 4,753 4,067 12,614 8,549
General and administrative 13,173 11,605 33,887 26,806
Research and development 2,705 2,110 7,715 4,044
Impairment of goodwill and long-lived assets 0 276 0 298
Total operating expenses 20,631 18,058 54,216 39,697
Operating income (loss) 22 (3,255) 8,062 6,896
Nonoperating expense:        
Interest expense and amortization of debt discount 1,950 1,929 5,803 3,522
Other expense (income), net 3,799 (107) 4,848 (748)
Total nonoperating expense 5,749 1,822 10,651 2,774
(Loss) earnings before income taxes (5,727) (5,077) (2,589) 4,122
Income tax (benefit) expense (1,185) (573) (1,943) 792
Net (loss) income $ (4,542) $ (4,504) $ (646) $ 3,330
(Loss) earnings per share:        
Basic (in dollars per share) $ (0.89) $ (1.03) $ (0.13) $ 0.80
Diluted (in dollars per share) $ (0.89) $ (1.03) $ (0.13) $ 0.75
Weighted-average common shares outstanding:        
Basic (in shares) 5,125 4,367 4,922 4,142
Diluted (in shares) 5,125 4,367 4,922 4,418
[1] Intersegment revenues are not significant and are eliminated to arrive at consolidated totals.